DOC — Healthpeak Properties, Inc.

Healthpeak Properties, Inc. (DOC) Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Q4 2025 Financials:
  • FFO as adjusted: $0.47 per share
  • AFFO: $0.40 per share
  • Same-store cash NOI growth: 3.9%
• Full Year 2025 Financials:
  • FFO as adjusted: $1.84 per share
  • AFFO: $1.69 per share
  • Same-store cash NOI growth: 4%
• Balance Sheet:
  • Net debt to adjusted EBITDA: 5.2 times
  • Liquidity: $2.4 billion

2. Strategic Updates and Business Highlights

• Merger with Physicians Realty Trust: Created a strong outpatient platform, yielding $70 million in synergies.
• Outpatient Medical Segment:
  • 50% of portfolio income; achieved record leasing of 4.9 million square feet, including 1 million square feet of new leasing.
  • Cash releasing spreads of 5% on renewals and 91% total occupancy.
• Lab Segment:
  • Experienced a challenging environment, with 1.5% same-store growth and total occupancy at 77%.
  • Anticipated improvement in capital raising and M&A activity.
• Senior Housing:
  • Achieved 17% same-store growth, driven by amenitized campuses and strong asset management.
  • Plans to create a pure-play senior housing REIT, Janus Living, by contributing the entire senior housing portfolio for an IPO.

3. Forward Guidance and Outlook

• 2026 Guidance:
  • FFO as adjusted expected to range from $1.70 to $1.74 per share.
  • Total same-store NOI growth forecasted between -1% to +1%, with outpatient medical expected to grow 2-3%, lab down 5-10%, and senior housing 8-12%.
• Transaction Activity:
  • Completed $464 million in acquisitions in early 2026, with an additional $360 million in the senior housing pipeline.
  • Plans for $1 billion or more in asset sales and recapitalizations in 2026.

4. Bad News, Challenges, or Points of Concern

• Lab Segment Challenges:
  • Declining occupancy and negative NOI growth expected in 2026 due to recent expirations and a lag in earnings recovery.
• Interest Rate Impact:
  • Higher refinancing costs affecting earnings; $150 million loan proceeds at approximately 10% interest rate.
• Market Conditions:
  • The life science environment remains uncertain, with occupancy recovery expected to lag behind improvements in capital markets.

5. Notable Q&A Insights

• Gateway Acquisition: Management expressed confidence in the long-term potential of the Gateway acquisition, viewing it as a strategic opportunity to enhance their portfolio despite current vacancies.
• Lab Segment Outlook: Management indicated that while occupancy is expected to improve by year-end 2026, the pace of recovery will depend on capital market conditions.
• Tenant Composition: The pipeline includes a mix of established biotech firms and early-stage companies, with a noted increase in leasing activity from traditional wet lab users.
• Transition of Senior Housing Assets: Anticipated minor occupancy declines during the transition to new operators, but significant NOI growth potential over the next few years is expected.

Overall, Healthpeak Properties demonstrated resilience in its outpatient medical and senior housing segments while navigating challenges in the lab segment. The strategic move towards a pure-play senior housing REIT reflects a focus on optimizing asset value and positioning for future growth.